

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T-helper cell differentiation (GO:0045623) | 6.31860869 |
| 2 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 6.31860869 |
| 3 | negative regulation of B cell mediated immunity (GO:0002713) | 6.01447112 |
| 4 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 6.01447112 |
| 5 | germinal center formation (GO:0002467) | 5.71716337 |
| 6 | regulation of memory T cell differentiation (GO:0043380) | 5.54734921 |
| 7 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 5.54307199 |
| 8 | regulation of T-helper 2 cell differentiation (GO:0045628) | 5.33384605 |
| 9 | * negative regulation of B cell apoptotic process (GO:0002903) | 4.92183658 |
| 10 | negative regulation of type 2 immune response (GO:0002829) | 4.89001729 |
| 11 | DNA deamination (GO:0045006) | 4.85842999 |
| 12 | regulation of mitotic spindle organization (GO:0060236) | 4.68866346 |
| 13 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.56372198 |
| 14 | positive regulation of receptor biosynthetic process (GO:0010870) | 4.29835354 |
| 15 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.25907441 |
| 16 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.25907441 |
| 17 | keratinocyte development (GO:0003334) | 4.24690066 |
| 18 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.20882127 |
| 19 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 4.14313789 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.08504251 |
| 21 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.01762122 |
| 22 | platelet dense granule organization (GO:0060155) | 3.94578163 |
| 23 | regulation of cholesterol storage (GO:0010885) | 3.92558578 |
| 24 | * regulation of B cell apoptotic process (GO:0002902) | 3.89048553 |
| 25 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.88649273 |
| 26 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.85404022 |
| 27 | regulation of germinal center formation (GO:0002634) | 3.80847061 |
| 28 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.80736768 |
| 29 | apoptotic cell clearance (GO:0043277) | 3.77419997 |
| 30 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.77125510 |
| 31 | negative regulation of digestive system process (GO:0060457) | 3.73559167 |
| 32 | response to pheromone (GO:0019236) | 3.73012139 |
| 33 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.72098912 |
| 34 | cytidine metabolic process (GO:0046087) | 3.69922063 |
| 35 | cytidine catabolic process (GO:0006216) | 3.69922063 |
| 36 | cytidine deamination (GO:0009972) | 3.69922063 |
| 37 | regulation of response to interferon-gamma (GO:0060330) | 3.69831082 |
| 38 | positive regulation of cholesterol efflux (GO:0010875) | 3.67496361 |
| 39 | negative regulation of lipid storage (GO:0010888) | 3.64366717 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61084672 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61084672 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 3.60587431 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.58011981 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55622120 |
| 45 | regulation of spindle organization (GO:0090224) | 3.50672389 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.49579736 |
| 47 | positive regulation of protein autophosphorylation (GO:0031954) | 3.49555611 |
| 48 | proteasome assembly (GO:0043248) | 3.45505267 |
| 49 | protein K11-linked deubiquitination (GO:0035871) | 3.41100111 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 3.32730581 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 3.32730581 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.32730581 |
| 53 | NLS-bearing protein import into nucleus (GO:0006607) | 3.32287154 |
| 54 | DNA double-strand break processing (GO:0000729) | 3.30769519 |
| 55 | negative regulation of innate immune response (GO:0045824) | 3.27539824 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.23361970 |
| 57 | regulation of T-helper cell differentiation (GO:0045622) | 3.15204443 |
| 58 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.11959876 |
| 59 | positive regulation of sterol transport (GO:0032373) | 3.11311121 |
| 60 | positive regulation of cholesterol transport (GO:0032376) | 3.11311121 |
| 61 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.10592901 |
| 62 | negative regulation of mast cell activation (GO:0033004) | 3.10147261 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 3.07469726 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 3.06907260 |
| 65 | regulation of interleukin-8 secretion (GO:2000482) | 3.04486986 |
| 66 | cytochrome complex assembly (GO:0017004) | 3.02846072 |
| 67 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.02830154 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02542980 |
| 69 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.01938464 |
| 70 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.00668719 |
| 71 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.00668719 |
| 72 | isotype switching (GO:0045190) | 3.00668719 |
| 73 | * immunoglobulin mediated immune response (GO:0016064) | 3.00245427 |
| 74 | signal peptide processing (GO:0006465) | 2.99952352 |
| 75 | lactate metabolic process (GO:0006089) | 2.98879285 |
| 76 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.98063178 |
| 77 | intestinal epithelial cell development (GO:0060576) | 2.96265264 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.93940535 |
| 79 | transepithelial transport (GO:0070633) | 2.93897692 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93833552 |
| 81 | kynurenine metabolic process (GO:0070189) | 2.93721412 |
| 82 | protein complex biogenesis (GO:0070271) | 2.93531424 |
| 83 | L-fucose metabolic process (GO:0042354) | 2.91761034 |
| 84 | L-fucose catabolic process (GO:0042355) | 2.91761034 |
| 85 | fucose catabolic process (GO:0019317) | 2.91761034 |
| 86 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.89289397 |
| 87 | protein prenylation (GO:0018342) | 2.88753209 |
| 88 | prenylation (GO:0097354) | 2.88753209 |
| 89 | magnesium ion transport (GO:0015693) | 2.87351199 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 2.87146292 |
| 91 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.86540018 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.85636833 |
| 93 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.85044001 |
| 94 | protein K6-linked ubiquitination (GO:0085020) | 2.84627742 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 2.83002637 |
| 96 | regulation of isotype switching (GO:0045191) | 2.82107372 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.79991748 |
| 98 | maturation of 5.8S rRNA (GO:0000460) | 2.76017132 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 2.75502543 |
| 100 | negative regulation of protein autophosphorylation (GO:0031953) | 2.75316517 |
| 101 | multicellular organism reproduction (GO:0032504) | 2.75133213 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74724648 |
| 103 | modulation by symbiont of host defense response (GO:0052031) | 2.74724648 |
| 104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74724648 |
| 105 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74724648 |
| 106 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74724648 |
| 107 | modulation by symbiont of host immune response (GO:0052553) | 2.74724648 |
| 108 | regulation of hexokinase activity (GO:1903299) | 2.72617244 |
| 109 | regulation of glucokinase activity (GO:0033131) | 2.72617244 |
| 110 | regulation of metalloenzyme activity (GO:0048552) | 2.71321484 |
| 111 | sulfation (GO:0051923) | 2.71162808 |
| 112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.71047110 |
| 113 | regulation of protein autophosphorylation (GO:0031952) | 2.70674497 |
| 114 | response to peptidoglycan (GO:0032494) | 2.69087740 |
| 115 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68648962 |
| 116 | leukocyte aggregation (GO:0070486) | 2.68334019 |
| 117 | amine catabolic process (GO:0009310) | 2.68326647 |
| 118 | cellular biogenic amine catabolic process (GO:0042402) | 2.68326647 |
| 119 | regulation of type 2 immune response (GO:0002828) | 2.68281615 |
| 120 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.66778367 |
| 121 | NADH dehydrogenase complex assembly (GO:0010257) | 2.66778367 |
| 122 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.66778367 |
| 123 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.66076049 |
| 124 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.66054619 |
| 125 | regulation of B cell differentiation (GO:0045577) | 2.65946792 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.65825647 |
| 127 | protein import into nucleus, translocation (GO:0000060) | 2.64303338 |
| 128 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63890706 |
| 129 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.62880127 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62539103 |
| 131 | * cellular defense response (GO:0006968) | 2.61789059 |
| 132 | protein neddylation (GO:0045116) | 2.61647416 |
| 133 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.61398454 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.60595081 |
| 135 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.58632297 |
| 136 | cullin deneddylation (GO:0010388) | 2.58153197 |
| 137 | positive regulation of actin filament depolymerization (GO:0030836) | 2.56425904 |
| 138 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.55548557 |
| 139 | regulation of B cell mediated immunity (GO:0002712) | 2.55165303 |
| 140 | cellular response to zinc ion (GO:0071294) | 2.55020221 |
| 141 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54528402 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.53414762 |
| 143 | negative regulation of B cell activation (GO:0050869) | 2.53405492 |
| 144 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.53134774 |
| 145 | regulation of cholesterol efflux (GO:0010874) | 2.52538504 |
| 146 | * B cell mediated immunity (GO:0019724) | 2.51559959 |
| 147 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.51231490 |
| 148 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.51231490 |
| 149 | positive regulation of prostaglandin secretion (GO:0032308) | 2.50773157 |
| 150 | negative regulation of neurological system process (GO:0031645) | 2.48920082 |
| 151 | GPI anchor metabolic process (GO:0006505) | 2.48494682 |
| 152 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.48481064 |
| 153 | intracellular transport of virus (GO:0075733) | 2.47959272 |
| 154 | multi-organism transport (GO:0044766) | 2.47959272 |
| 155 | multi-organism localization (GO:1902579) | 2.47959272 |
| 156 | multi-organism intracellular transport (GO:1902583) | 2.47959272 |
| 157 | transport of virus (GO:0046794) | 2.47959272 |
| 158 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.47884183 |
| 159 | neutrophil activation (GO:0042119) | 2.46662628 |
| 160 | positive regulation of B cell proliferation (GO:0030890) | 2.46582399 |
| 161 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46297715 |
| 162 | ribosomal small subunit assembly (GO:0000028) | 2.46252279 |
| 163 | respiratory burst (GO:0045730) | 2.44589575 |
| 164 | response to thyroid hormone (GO:0097066) | 2.44316526 |
| 165 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.44063719 |
| 166 | regulation of glomerulus development (GO:0090192) | 2.43312910 |
| 167 | viral transcription (GO:0019083) | 2.42788538 |
| 168 | DNA demethylation (GO:0080111) | 2.42528508 |
| 169 | negative regulation of interleukin-12 production (GO:0032695) | 2.41680912 |
| 170 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.40425476 |
| 171 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.40352275 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.40028070 |
| 173 | regulation of DNA endoreduplication (GO:0032875) | 2.39872371 |
| 174 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.39600349 |
| 175 | peptidyl-histidine modification (GO:0018202) | 2.39473977 |
| 176 | protein deneddylation (GO:0000338) | 2.39457855 |
| 177 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.36894797 |
| 178 | nucleotide transmembrane transport (GO:1901679) | 2.35415208 |
| 179 | cobalamin metabolic process (GO:0009235) | 2.35352030 |
| 180 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.35096374 |
| 181 | mannosylation (GO:0097502) | 2.34764808 |
| 182 | negative regulation of telomere maintenance (GO:0032205) | 2.34649015 |
| 183 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.34444005 |
| 184 | kidney morphogenesis (GO:0060993) | 2.33130156 |
| 185 | protein-cofactor linkage (GO:0018065) | 2.32943296 |
| 186 | histamine secretion (GO:0001821) | 2.32829841 |
| 187 | C-terminal protein lipidation (GO:0006501) | 2.32746479 |
| 188 | regulation of meiosis I (GO:0060631) | 2.32663562 |
| 189 | rRNA methylation (GO:0031167) | 2.32597414 |
| 190 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.30904482 |
| 191 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.30904482 |
| 192 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.30904482 |
| 193 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.29345629 |
| 194 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.28842158 |
| 195 | rRNA modification (GO:0000154) | 2.28455261 |
| 196 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.28296816 |
| 197 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.28296816 |
| 198 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.27451828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76612178 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.32944011 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.14514868 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.68569563 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33800838 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.24709874 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17920429 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.82945138 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78863169 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.74847620 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69920502 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66559670 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62271334 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57060890 |
| 15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54252031 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.50309429 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.46622250 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44995345 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.41168184 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.39114619 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38168333 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35957566 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35931941 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34714551 |
| 25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.32010737 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23533947 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18836446 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16963937 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09935392 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.08617368 |
| 31 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08354941 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.07057554 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 2.04106194 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 2.03894787 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03499209 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 2.00065139 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.99413397 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99143098 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99010902 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.98261464 |
| 41 | * MAF_26560356_Chip-Seq_TH1_Human | 1.97477360 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.94897356 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93551101 |
| 44 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.92110984 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89665542 |
| 46 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86180691 |
| 47 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82308989 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80032867 |
| 49 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76403315 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75682669 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73914279 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71285371 |
| 53 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71183417 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69052967 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.68191076 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66735509 |
| 57 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65119224 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63726844 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59603477 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57903672 |
| 61 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.56801856 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56602336 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.54654551 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52859614 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51859021 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51750944 |
| 67 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.50835752 |
| 68 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50815277 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.50261132 |
| 70 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50073691 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48894164 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45306823 |
| 73 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43533441 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43027911 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42148568 |
| 76 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.42103470 |
| 77 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.42103470 |
| 78 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41999066 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40911186 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40707130 |
| 81 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40595615 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40176708 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39216267 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.37610091 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35995109 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33892743 |
| 87 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33746218 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32945350 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32872380 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32867996 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32867996 |
| 92 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.31679885 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29661273 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28912283 |
| 95 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28638645 |
| 96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28620914 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28303252 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28121112 |
| 99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27953183 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26454411 |
| 101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26346804 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25178758 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25142192 |
| 104 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24769231 |
| 105 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24769231 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24364016 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23919973 |
| 108 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23629595 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23133110 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22505225 |
| 111 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22199483 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21519207 |
| 113 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21350778 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21024835 |
| 115 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20950327 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19856109 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19675400 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19447307 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19218476 |
| 120 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18960032 |
| 121 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18240330 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18180055 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17882647 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 1.17547958 |
| 125 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17336754 |
| 126 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16924258 |
| 127 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16748163 |
| 128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16748015 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16549939 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15757888 |
| 131 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15628078 |
| 132 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14598066 |
| 133 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14491927 |
| 134 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14491927 |
| 135 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12473582 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12372496 |
| 137 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11549790 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10746711 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09868402 |
| 140 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09394803 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09291121 |
| 142 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09230101 |
| 143 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09209160 |
| 144 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.09176516 |
| 145 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08848564 |
| 146 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08781585 |
| 147 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08620044 |
| 148 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08537403 |
| 149 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08277871 |
| 150 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08095075 |
| 151 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07820010 |
| 152 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07697156 |
| 153 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07370802 |
| 154 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07108777 |
| 155 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07073967 |
| 156 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06847199 |
| 157 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06707762 |
| 158 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06200816 |
| 159 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05768290 |
| 160 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05762833 |
| 161 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05658813 |
| 162 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05336732 |
| 163 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04950711 |
| 164 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04817758 |
| 165 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04474406 |
| 166 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04391495 |
| 167 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03234409 |
| 168 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02750177 |
| 169 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02457310 |
| 170 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02398073 |
| 171 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01854692 |
| 172 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01698514 |
| 173 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01300482 |
| 174 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99975394 |
| 175 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99035919 |
| 176 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98712716 |
| 177 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98189403 |
| 178 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96804603 |
| 179 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94963242 |
| 180 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93977194 |
| 181 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93869690 |
| 182 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93511943 |
| 183 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92983331 |
| 184 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91508020 |
| 185 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90892854 |
| 186 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89466345 |
| 187 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89063292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.27207904 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.91104009 |
| 3 | MP0003195_calcinosis | 4.16266319 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.95100360 |
| 5 | MP0000685_abnormal_immune_system | 3.55112406 |
| 6 | MP0001853_heart_inflammation | 3.44563284 |
| 7 | MP0002163_abnormal_gland_morphology | 3.41899531 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.15859063 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.99272712 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.86866957 |
| 11 | MP0009785_altered_susceptibility_to | 2.79232235 |
| 12 | MP0003436_decreased_susceptibility_to | 2.73276531 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 2.50084361 |
| 14 | MP0005387_immune_system_phenotype | 2.42992919 |
| 15 | MP0001790_abnormal_immune_system | 2.42992919 |
| 16 | MP0005671_abnormal_response_to | 2.42160558 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.39238909 |
| 18 | MP0003724_increased_susceptibility_to | 2.34545921 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.32267258 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.32199616 |
| 21 | MP0003303_peritoneal_inflammation | 2.32017049 |
| 22 | MP0002102_abnormal_ear_morphology | 2.31913880 |
| 23 | * MP0001800_abnormal_humoral_immune | 2.26988765 |
| 24 | MP0000613_abnormal_salivary_gland | 2.24939259 |
| 25 | * MP0005025_abnormal_response_to | 2.24307019 |
| 26 | MP0008877_abnormal_DNA_methylation | 2.18069640 |
| 27 | * MP0002452_abnormal_antigen_presenting | 2.16543979 |
| 28 | MP0002419_abnormal_innate_immunity | 2.10133290 |
| 29 | * MP0002723_abnormal_immune_serum | 2.07870873 |
| 30 | MP0002405_respiratory_system_inflammati | 2.07030382 |
| 31 | MP0002876_abnormal_thyroid_physiology | 2.01134851 |
| 32 | * MP0002420_abnormal_adaptive_immunity | 1.96903772 |
| 33 | * MP0001819_abnormal_immune_cell | 1.96043083 |
| 34 | MP0008872_abnormal_physiological_respon | 1.93456448 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.87893614 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.76384233 |
| 37 | MP0006082_CNS_inflammation | 1.75703579 |
| 38 | MP0000604_amyloidosis | 1.74425663 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.71581478 |
| 40 | MP0005367_renal/urinary_system_phenotyp | 1.71061994 |
| 41 | MP0000516_abnormal_urinary_system | 1.71061994 |
| 42 | * MP0002398_abnormal_bone_marrow | 1.68918032 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.68736389 |
| 44 | MP0003786_premature_aging | 1.68190812 |
| 45 | MP0003329_amyloid_beta_deposits | 1.67631053 |
| 46 | MP0003252_abnormal_bile_duct | 1.67027156 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.66492858 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.63905403 |
| 49 | MP0003011_delayed_dark_adaptation | 1.60886118 |
| 50 | MP0004947_skin_inflammation | 1.60659747 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.58892616 |
| 52 | MP0003718_maternal_effect | 1.56577002 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.56258804 |
| 54 | MP0000427_abnormal_hair_cycle | 1.55550197 |
| 55 | * MP0000716_abnormal_immune_system | 1.52290292 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.52207114 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.51963922 |
| 58 | MP0005410_abnormal_fertilization | 1.51937557 |
| 59 | MP0002928_abnormal_bile_duct | 1.51906319 |
| 60 | MP0008469_abnormal_protein_level | 1.51463516 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49264152 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.48542353 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.46504590 |
| 64 | MP0008058_abnormal_DNA_repair | 1.44994758 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.44526217 |
| 66 | * MP0000689_abnormal_spleen_morphology | 1.43410588 |
| 67 | MP0002006_tumorigenesis | 1.40424679 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.39806161 |
| 69 | MP0002722_abnormal_immune_system | 1.39322103 |
| 70 | MP0005083_abnormal_biliary_tract | 1.39223955 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.35729955 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.35270796 |
| 73 | MP0006054_spinal_hemorrhage | 1.34672631 |
| 74 | * MP0002429_abnormal_blood_cell | 1.34043439 |
| 75 | MP0002166_altered_tumor_susceptibility | 1.32975589 |
| 76 | MP0003448_altered_tumor_morphology | 1.30201231 |
| 77 | MP0002132_abnormal_respiratory_system | 1.30005285 |
| 78 | MP0005389_reproductive_system_phenotype | 1.27845251 |
| 79 | MP0003828_pulmonary_edema | 1.27537769 |
| 80 | MP0009697_abnormal_copulation | 1.27021025 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.27002254 |
| 82 | MP0000490_abnormal_crypts_of | 1.26564750 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 1.26472515 |
| 84 | MP0001545_abnormal_hematopoietic_system | 1.26472515 |
| 85 | MP0000858_altered_metastatic_potential | 1.25511506 |
| 86 | MP0009278_abnormal_bone_marrow | 1.24625571 |
| 87 | MP0001764_abnormal_homeostasis | 1.18026883 |
| 88 | MP0005253_abnormal_eye_physiology | 1.16275988 |
| 89 | MP0000343_altered_response_to | 1.15460224 |
| 90 | MP0008007_abnormal_cellular_replicative | 1.14922354 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 1.13219137 |
| 92 | MP0002254_reproductive_system_inflammat | 1.12021971 |
| 93 | MP0002933_joint_inflammation | 1.11752292 |
| 94 | MP0004510_myositis | 1.10498313 |
| 95 | MP0003566_abnormal_cell_adhesion | 1.09904507 |
| 96 | MP0005023_abnormal_wound_healing | 1.08896102 |
| 97 | * MP0000703_abnormal_thymus_morphology | 1.08216949 |
| 98 | MP0004484_altered_response_of | 1.07385060 |
| 99 | MP0003693_abnormal_embryo_hatching | 1.05376265 |
| 100 | MP0001851_eye_inflammation | 1.03332030 |
| 101 | MP0002282_abnormal_trachea_morphology | 1.03109500 |
| 102 | MP0001873_stomach_inflammation | 1.03007657 |
| 103 | MP0000647_abnormal_sebaceous_gland | 1.02999239 |
| 104 | MP0005058_abnormal_lysosome_morphology | 1.02139367 |
| 105 | MP0009764_decreased_sensitivity_to | 1.01891061 |
| 106 | MP0005395_other_phenotype | 1.01817548 |
| 107 | MP0004043_abnormal_pH_regulation | 1.01585446 |
| 108 | MP0003866_abnormal_defecation | 0.99308926 |
| 109 | MP0009379_abnormal_foot_pigmentation | 0.98079262 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.97545376 |
| 111 | MP0003186_abnormal_redox_activity | 0.96741471 |
| 112 | MP0002160_abnormal_reproductive_system | 0.96001689 |
| 113 | MP0008057_abnormal_DNA_replication | 0.94939074 |
| 114 | MP0001919_abnormal_reproductive_system | 0.94560748 |
| 115 | MP0005360_urolithiasis | 0.94469878 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.94049561 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.91489162 |
| 118 | MP0006292_abnormal_olfactory_placode | 0.89217863 |
| 119 | MP0005647_abnormal_sex_gland | 0.89020170 |
| 120 | MP0003787_abnormal_imprinting | 0.88392172 |
| 121 | MP0005332_abnormal_amino_acid | 0.88102220 |
| 122 | MP0000249_abnormal_blood_vessel | 0.87232184 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.87144765 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.86459748 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.85388862 |
| 126 | MP0005390_skeleton_phenotype | 0.85194506 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.84437981 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.82629629 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.82549240 |
| 130 | MP0003279_aneurysm | 0.80193329 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.79625855 |
| 132 | MP0004957_abnormal_blastocyst_morpholog | 0.78681409 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.78287839 |
| 134 | MP0005310_abnormal_salivary_gland | 0.77995162 |
| 135 | MP0001485_abnormal_pinna_reflex | 0.77280784 |
| 136 | MP0009763_increased_sensitivity_to | 0.76319496 |
| 137 | MP0001119_abnormal_female_reproductive | 0.76076925 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.75806667 |
| 139 | MP0005365_abnormal_bile_salt | 0.75324376 |
| 140 | MP0000538_abnormal_urinary_bladder | 0.75185300 |
| 141 | MP0003077_abnormal_cell_cycle | 0.74156464 |
| 142 | MP0002133_abnormal_respiratory_system | 0.72687474 |
| 143 | MP0005388_respiratory_system_phenotype | 0.72687474 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.72173147 |
| 145 | MP0005646_abnormal_pituitary_gland | 0.71030047 |
| 146 | MP0001756_abnormal_urination | 0.70936937 |
| 147 | MP0002168_other_aberrant_phenotype | 0.70492040 |
| 148 | MP0001542_abnormal_bone_strength | 0.70180526 |
| 149 | MP0000383_abnormal_hair_follicle | 0.69585976 |
| 150 | MP0001243_abnormal_dermal_layer | 0.69461195 |
| 151 | MP0005075_abnormal_melanosome_morpholog | 0.69041639 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.68570229 |
| 153 | MP0001216_abnormal_epidermal_layer | 0.68355873 |
| 154 | MP0003091_abnormal_cell_migration | 0.68003068 |
| 155 | MP0003646_muscle_fatigue | 0.67332758 |
| 156 | MP0005166_decreased_susceptibility_to | 0.66766039 |
| 157 | MP0003075_altered_response_to | 0.66222813 |
| 158 | MP0002751_abnormal_autonomic_nervous | 0.65588046 |
| 159 | MP0002060_abnormal_skin_morphology | 0.64152041 |
| 160 | MP0002277_abnormal_respiratory_mucosa | 0.63661503 |
| 161 | MP0010234_abnormal_vibrissa_follicle | 0.62016758 |
| 162 | MP0003705_abnormal_hypodermis_morpholog | 0.61414491 |
| 163 | MP0005319_abnormal_enzyme/_coenzyme | 0.60409904 |
| 164 | MP0000609_abnormal_liver_physiology | 0.59163266 |
| 165 | MP0003795_abnormal_bone_structure | 0.58423982 |
| 166 | MP0003806_abnormal_nucleotide_metabolis | 0.58340947 |
| 167 | MP0008260_abnormal_autophagy | 0.58131355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mediastinal lymphadenopathy (HP:0100721) | 5.72062806 |
| 2 | Parakeratosis (HP:0001036) | 5.39571861 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.13265071 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.80597190 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.29160540 |
| 6 | Abnormality of the peritoneum (HP:0002585) | 4.18591193 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.07491350 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 3.93950770 |
| 9 | Amniotic constriction ring (HP:0009775) | 3.93662634 |
| 10 | Abnormality of placental membranes (HP:0011409) | 3.93662634 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.77850944 |
| 12 | Stomatitis (HP:0010280) | 3.74013496 |
| 13 | Chronic otitis media (HP:0000389) | 3.66136820 |
| 14 | Pancreatic cysts (HP:0001737) | 3.60882010 |
| 15 | Abnormality of T cell physiology (HP:0011840) | 3.59155665 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.58700126 |
| 17 | Myositis (HP:0100614) | 3.56644320 |
| 18 | Meningitis (HP:0001287) | 3.48660042 |
| 19 | Type 2 muscle fiber atrophy (HP:0003554) | 3.36368412 |
| 20 | Muscle fiber atrophy (HP:0100295) | 3.35868310 |
| 21 | Granulocytopenia (HP:0001913) | 3.24585185 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.23031845 |
| 23 | Pancreatic fibrosis (HP:0100732) | 3.19871247 |
| 24 | Cellulitis (HP:0100658) | 3.18571940 |
| 25 | Hypothermia (HP:0002045) | 3.17683040 |
| 26 | True hermaphroditism (HP:0010459) | 3.11405625 |
| 27 | Methylmalonic acidemia (HP:0002912) | 3.08142638 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.06944916 |
| 29 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.03685704 |
| 30 | Recurrent viral infections (HP:0004429) | 2.98908644 |
| 31 | Pustule (HP:0200039) | 2.98513607 |
| 32 | Abnormality of T cells (HP:0002843) | 2.89898271 |
| 33 | Orchitis (HP:0100796) | 2.84781766 |
| 34 | Conjunctival hamartoma (HP:0100780) | 2.83100436 |
| 35 | Recurrent skin infections (HP:0001581) | 2.81565702 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.76324552 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.74568434 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70103492 |
| 39 | Obstructive lung disease (HP:0006536) | 2.70103492 |
| 40 | Abnormality of the pleura (HP:0002103) | 2.68606950 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.68121647 |
| 42 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.65950626 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 2.64397047 |
| 44 | Gingivitis (HP:0000230) | 2.61648575 |
| 45 | Pendular nystagmus (HP:0012043) | 2.61369889 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.60768661 |
| 47 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.59638329 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.56979177 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56956224 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.56942357 |
| 51 | Leukocytosis (HP:0001974) | 2.56673729 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.56488228 |
| 53 | Lymphopenia (HP:0001888) | 2.55758915 |
| 54 | Methylmalonic aciduria (HP:0012120) | 2.55269639 |
| 55 | Vasculitis (HP:0002633) | 2.54968005 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.54684576 |
| 57 | Hamartoma of the eye (HP:0010568) | 2.54638869 |
| 58 | Increased CSF lactate (HP:0002490) | 2.53903917 |
| 59 | Weak cry (HP:0001612) | 2.51254663 |
| 60 | Thyroiditis (HP:0100646) | 2.50667881 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.48612231 |
| 62 | Glomerulonephritis (HP:0000099) | 2.48203997 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.47269026 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.46339102 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.46339102 |
| 66 | IgM deficiency (HP:0002850) | 2.44130440 |
| 67 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.43198566 |
| 68 | Optic neuritis (HP:0100653) | 2.42609190 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.42609190 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.40661018 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40112511 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.38597160 |
| 73 | Thrombocytosis (HP:0001894) | 2.36700190 |
| 74 | Nonprogressive disorder (HP:0003680) | 2.36254252 |
| 75 | Skin ulcer (HP:0200042) | 2.36186638 |
| 76 | Acute encephalopathy (HP:0006846) | 2.36056670 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.35307822 |
| 78 | Fatigable weakness (HP:0003473) | 2.35307822 |
| 79 | Furrowed tongue (HP:0000221) | 2.34848105 |
| 80 | Hypoplasia of the uterus (HP:0000013) | 2.34847796 |
| 81 | Hematochezia (HP:0002573) | 2.34448224 |
| 82 | Abnormality of vitamin B metabolism (HP:0004340) | 2.33050283 |
| 83 | Petechiae (HP:0000967) | 2.32578170 |
| 84 | Hypoproteinemia (HP:0003075) | 2.32327876 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.30817994 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.30571527 |
| 87 | Hepatocellular necrosis (HP:0001404) | 2.28512545 |
| 88 | Metaphyseal dysplasia (HP:0100255) | 2.28331370 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27694534 |
| 90 | Keratoconus (HP:0000563) | 2.26772908 |
| 91 | Increased corneal curvature (HP:0100692) | 2.26772908 |
| 92 | Urticaria (HP:0001025) | 2.25196617 |
| 93 | Prostate neoplasm (HP:0100787) | 2.24735719 |
| 94 | Joint swelling (HP:0001386) | 2.24358369 |
| 95 | Azoospermia (HP:0000027) | 2.23936201 |
| 96 | Decreased central vision (HP:0007663) | 2.23796660 |
| 97 | Osteomyelitis (HP:0002754) | 2.23563999 |
| 98 | Sepsis (HP:0100806) | 2.21197774 |
| 99 | Stenosis of the external auditory canal (HP:0000402) | 2.19099381 |
| 100 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16797979 |
| 101 | Abnormality of macular pigmentation (HP:0008002) | 2.16161802 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.14698216 |
| 103 | Nephronophthisis (HP:0000090) | 2.14309611 |
| 104 | Abnormality of T cell number (HP:0011839) | 2.14186396 |
| 105 | Panhypogammaglobulinemia (HP:0003139) | 2.13971690 |
| 106 | Posterior subcapsular cataract (HP:0007787) | 2.12369632 |
| 107 | Microglossia (HP:0000171) | 2.11907727 |
| 108 | Hepatic necrosis (HP:0002605) | 2.11409353 |
| 109 | Tubular atrophy (HP:0000092) | 2.11254856 |
| 110 | Renal cortical cysts (HP:0000803) | 2.11220768 |
| 111 | Abnormality of the renal medulla (HP:0100957) | 2.10018301 |
| 112 | Periodontitis (HP:0000704) | 2.09694551 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 2.08857364 |
| 114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08857364 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.08418752 |
| 116 | Pulmonary infiltrates (HP:0002113) | 2.08192227 |
| 117 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08056585 |
| 118 | Agammaglobulinemia (HP:0004432) | 2.06368837 |
| 119 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05852898 |
| 120 | Disproportionate short-trunk short stature (HP:0003521) | 2.05724645 |
| 121 | Skin rash (HP:0000988) | 2.05648964 |
| 122 | Abnormal number of erythroid precursors (HP:0012131) | 2.05461040 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 2.05236474 |
| 124 | Meningioma (HP:0002858) | 2.04429671 |
| 125 | Spontaneous hematomas (HP:0007420) | 2.04277464 |
| 126 | Abnormal spermatogenesis (HP:0008669) | 2.04010163 |
| 127 | Severe visual impairment (HP:0001141) | 2.02563289 |
| 128 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.00749150 |
| 129 | T lymphocytopenia (HP:0005403) | 2.00733737 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 2.00517680 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00261553 |
| 132 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00261553 |
| 133 | Chorioretinal atrophy (HP:0000533) | 2.00212763 |
| 134 | Abnormality of the nasal mucosa (HP:0000433) | 1.99992546 |
| 135 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99666636 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.98166169 |
| 137 | Peritonitis (HP:0002586) | 1.96053623 |
| 138 | Hemiplegia (HP:0002301) | 1.95837984 |
| 139 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.94659723 |
| 140 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.93378054 |
| 141 | Epistaxis (HP:0000421) | 1.93362327 |
| 142 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.92551765 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92279787 |
| 144 | Arterial thrombosis (HP:0004420) | 1.91923840 |
| 145 | Increased IgM level (HP:0003496) | 1.91581700 |
| 146 | Nasal polyposis (HP:0100582) | 1.91352950 |
| 147 | Increased hepatocellular lipid droplets (HP:0006565) | 1.91341077 |
| 148 | Short tibia (HP:0005736) | 1.90997988 |
| 149 | Eosinophilia (HP:0001880) | 1.90452492 |
| 150 | Medial flaring of the eyebrow (HP:0010747) | 1.90136055 |
| 151 | Hemoptysis (HP:0002105) | 1.89972039 |
| 152 | Thick nail (HP:0001805) | 1.89385227 |
| 153 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89094876 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.88857036 |
| 155 | Emphysema (HP:0002097) | 1.88709965 |
| 156 | Gaze-evoked nystagmus (HP:0000640) | 1.88344277 |
| 157 | Nail dystrophy (HP:0008404) | 1.87876891 |
| 158 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86683637 |
| 159 | Adrenal hypoplasia (HP:0000835) | 1.86616008 |
| 160 | Easy fatigability (HP:0003388) | 1.86288547 |
| 161 | Abnormal pancreas size (HP:0012094) | 1.85680232 |
| 162 | Inflammation of the large intestine (HP:0002037) | 1.84430655 |
| 163 | Abnormality of the pons (HP:0007361) | 1.84417340 |
| 164 | Stomach cancer (HP:0012126) | 1.84210293 |
| 165 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.83598119 |
| 166 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83518964 |
| 167 | Oral leukoplakia (HP:0002745) | 1.83430751 |
| 168 | Tongue fasciculations (HP:0001308) | 1.83190574 |
| 169 | Recurrent pneumonia (HP:0006532) | 1.83023067 |
| 170 | Abnormality of methionine metabolism (HP:0010901) | 1.82847072 |
| 171 | Abnormal biliary tract morphology (HP:0012440) | 1.82835326 |
| 172 | Constricted visual fields (HP:0001133) | 1.81124432 |
| 173 | Breast carcinoma (HP:0003002) | 1.80728249 |
| 174 | Exocrine pancreatic insufficiency (HP:0001738) | 1.80471250 |
| 175 | Abnormality of urine glucose concentration (HP:0011016) | 1.79816497 |
| 176 | Glycosuria (HP:0003076) | 1.79816497 |
| 177 | Abnormality of chromosome stability (HP:0003220) | 1.78594688 |
| 178 | Palpitations (HP:0001962) | 1.78214403 |
| 179 | Abnormal albumin level (HP:0012116) | 1.77896964 |
| 180 | Hypoalbuminemia (HP:0003073) | 1.77896964 |
| 181 | Small hand (HP:0200055) | 1.77806852 |
| 182 | Albinism (HP:0001022) | 1.77391526 |
| 183 | Progressive inability to walk (HP:0002505) | 1.76868327 |
| 184 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.75718007 |
| 185 | Hypoplasia of the fovea (HP:0007750) | 1.75718007 |
| 186 | Renal Fanconi syndrome (HP:0001994) | 1.75275095 |
| 187 | Optic disc pallor (HP:0000543) | 1.74770904 |
| 188 | Increased serum lactate (HP:0002151) | 1.74600353 |
| 189 | Abnormality of the nasal septum (HP:0000419) | 1.74220508 |
| 190 | Abnormality of B cell number (HP:0010975) | 1.71820792 |
| 191 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.70644384 |
| 192 | Male pseudohermaphroditism (HP:0000037) | 1.69261896 |
| 193 | IgG deficiency (HP:0004315) | 1.65603866 |
| 194 | Median cleft lip (HP:0000161) | 1.65325441 |
| 195 | Sparse eyelashes (HP:0000653) | 1.64483902 |
| 196 | Sensory axonal neuropathy (HP:0003390) | 1.64120361 |
| 197 | Cerebral edema (HP:0002181) | 1.64008733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 6.14685109 |
| 2 | FRK | 4.53474139 |
| 3 | MAP4K1 | 3.33402522 |
| 4 | MST4 | 3.06364914 |
| 5 | TRIM28 | 2.91380136 |
| 6 | MAP4K2 | 2.81896969 |
| 7 | GRK1 | 2.73549480 |
| 8 | MAP3K14 | 2.72290485 |
| 9 | NUAK1 | 2.52824558 |
| 10 | IRAK4 | 2.52242208 |
| 11 | TBK1 | 2.35455915 |
| 12 | MAP3K12 | 2.12307349 |
| 13 | BMPR1B | 2.09328988 |
| 14 | NME2 | 2.08466874 |
| 15 | STK39 | 2.08297121 |
| 16 | JAK3 | 2.08047795 |
| 17 | TYK2 | 2.03946517 |
| 18 | LMTK2 | 2.03557986 |
| 19 | PIM2 | 2.02736816 |
| 20 | ADRBK2 | 1.97411195 |
| 21 | STK10 | 1.89766483 |
| 22 | KIT | 1.88734424 |
| 23 | BCR | 1.85762025 |
| 24 | TEC | 1.83501312 |
| 25 | TXK | 1.82309303 |
| 26 | SIK3 | 1.78954017 |
| 27 | * IKBKB | 1.78315942 |
| 28 | ZAK | 1.77496423 |
| 29 | BLK | 1.77271816 |
| 30 | STK24 | 1.74842639 |
| 31 | OXSR1 | 1.73856208 |
| 32 | IRAK3 | 1.73138673 |
| 33 | ERBB3 | 1.72388330 |
| 34 | STK38L | 1.71728469 |
| 35 | RPS6KA4 | 1.66835322 |
| 36 | BRSK2 | 1.66470097 |
| 37 | TGFBR2 | 1.64970156 |
| 38 | ERN1 | 1.56110940 |
| 39 | WNK3 | 1.52065365 |
| 40 | PLK2 | 1.51200565 |
| 41 | TNIK | 1.50822837 |
| 42 | BTK | 1.49665988 |
| 43 | IKBKE | 1.48219778 |
| 44 | VRK2 | 1.48094539 |
| 45 | FER | 1.45531601 |
| 46 | NLK | 1.45197093 |
| 47 | LRRK2 | 1.44127815 |
| 48 | ITK | 1.43290633 |
| 49 | INSRR | 1.41159028 |
| 50 | FLT3 | 1.38677913 |
| 51 | PTK6 | 1.35593422 |
| 52 | MAP3K11 | 1.34992035 |
| 53 | MAP3K3 | 1.32436274 |
| 54 | ZAP70 | 1.31591794 |
| 55 | MAP2K3 | 1.22362236 |
| 56 | KDR | 1.21962296 |
| 57 | NEK9 | 1.19846574 |
| 58 | CHUK | 1.17438065 |
| 59 | TAF1 | 1.11845158 |
| 60 | PLK3 | 1.11348475 |
| 61 | PKN2 | 1.11026865 |
| 62 | CSF1R | 1.10258412 |
| 63 | PIM1 | 1.08845619 |
| 64 | STK3 | 1.08594481 |
| 65 | TAOK3 | 1.08345480 |
| 66 | PBK | 1.07155185 |
| 67 | CSK | 1.06855709 |
| 68 | EIF2AK3 | 1.04645814 |
| 69 | BUB1 | 1.04034555 |
| 70 | BMPR2 | 1.03112037 |
| 71 | EIF2AK1 | 1.03050085 |
| 72 | MAP3K10 | 1.01534871 |
| 73 | BCKDK | 0.99739882 |
| 74 | LCK | 0.98712966 |
| 75 | PAK3 | 0.98441108 |
| 76 | PRKCE | 0.98435896 |
| 77 | TGFBR1 | 0.97630958 |
| 78 | SYK | 0.97070620 |
| 79 | RIPK4 | 0.96110522 |
| 80 | PTK2B | 0.91729161 |
| 81 | STK16 | 0.91174867 |
| 82 | CLK1 | 0.90648137 |
| 83 | FGFR4 | 0.89668057 |
| 84 | CSNK1G1 | 0.87492448 |
| 85 | DYRK3 | 0.86729210 |
| 86 | GRK6 | 0.85540492 |
| 87 | HCK | 0.84502923 |
| 88 | JAK1 | 0.83596183 |
| 89 | CSNK1G3 | 0.82701048 |
| 90 | EPHA2 | 0.82511586 |
| 91 | EPHB1 | 0.81619484 |
| 92 | LYN | 0.81065220 |
| 93 | PDK2 | 0.80909753 |
| 94 | ACVR1B | 0.79599289 |
| 95 | MAP3K8 | 0.78519144 |
| 96 | MKNK2 | 0.78499082 |
| 97 | PINK1 | 0.77141329 |
| 98 | TLK1 | 0.75667917 |
| 99 | PRKCI | 0.75661318 |
| 100 | PAK4 | 0.73953961 |
| 101 | MKNK1 | 0.73635735 |
| 102 | MYLK | 0.73309323 |
| 103 | PRKG2 | 0.72561485 |
| 104 | CSNK1A1L | 0.72402138 |
| 105 | MAP3K13 | 0.71069906 |
| 106 | MATK | 0.68752436 |
| 107 | TESK1 | 0.68167692 |
| 108 | WNK4 | 0.67254470 |
| 109 | CSNK1G2 | 0.66800016 |
| 110 | AKT3 | 0.66163371 |
| 111 | PRKCQ | 0.65569944 |
| 112 | CASK | 0.63030000 |
| 113 | JAK2 | 0.62793412 |
| 114 | GRK7 | 0.62694288 |
| 115 | TESK2 | 0.62577880 |
| 116 | ADRBK1 | 0.62496667 |
| 117 | TAOK2 | 0.62417791 |
| 118 | NEK2 | 0.61796075 |
| 119 | WEE1 | 0.60550294 |
| 120 | STK4 | 0.57158491 |
| 121 | ERBB4 | 0.54989488 |
| 122 | MARK3 | 0.53159720 |
| 123 | MAP3K4 | 0.52002459 |
| 124 | RPS6KB2 | 0.50649240 |
| 125 | TRPM7 | 0.50083514 |
| 126 | TRIB3 | 0.49353544 |
| 127 | EIF2AK2 | 0.49004648 |
| 128 | EPHA3 | 0.48846219 |
| 129 | TTN | 0.48269206 |
| 130 | MAPKAPK2 | 0.47877593 |
| 131 | LIMK1 | 0.45544346 |
| 132 | TSSK6 | 0.45392689 |
| 133 | VRK1 | 0.44447200 |
| 134 | TIE1 | 0.44173288 |
| 135 | ABL1 | 0.41930933 |
| 136 | ABL2 | 0.41555309 |
| 137 | RPS6KA5 | 0.40460315 |
| 138 | FGFR2 | 0.39249094 |
| 139 | PAK1 | 0.39105408 |
| 140 | GRK5 | 0.38959647 |
| 141 | IGF1R | 0.38623964 |
| 142 | MAPK15 | 0.38104736 |
| 143 | MAP3K1 | 0.37685254 |
| 144 | EEF2K | 0.37015795 |
| 145 | SRPK1 | 0.37002451 |
| 146 | FGFR3 | 0.34873744 |
| 147 | PASK | 0.33965071 |
| 148 | PLK4 | 0.33958293 |
| 149 | CDK6 | 0.33956004 |
| 150 | IRAK1 | 0.33714240 |
| 151 | CAMKK2 | 0.33605347 |
| 152 | PIK3CG | 0.32958325 |
| 153 | MST1R | 0.32854889 |
| 154 | ROCK1 | 0.32434216 |
| 155 | DAPK1 | 0.31441146 |
| 156 | PRKCD | 0.31373335 |
| 157 | DYRK1B | 0.31259300 |
| 158 | MAPK4 | 0.31204586 |
| 159 | RAF1 | 0.31160689 |
| 160 | MAPKAPK3 | 0.30075056 |
| 161 | EGFR | 0.30074340 |
| 162 | PLK1 | 0.26344534 |
| 163 | PIK3CA | 0.25218816 |
| 164 | CSNK1A1 | 0.25088137 |
| 165 | MAPK13 | 0.24260835 |
| 166 | MAP2K7 | 0.23666050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81842867 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.72403622 |
| 3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42034162 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.38125853 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28850851 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.24308267 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23495108 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.23392406 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.21249671 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.15249555 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13633967 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.10317502 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.05997871 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.05578825 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.04317072 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.97408226 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.96549260 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94001064 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92972276 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.90470735 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.87860086 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.87778861 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87741716 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.86606561 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85863539 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85635192 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76969215 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.75829157 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.70367066 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.67658793 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65743532 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.63237103 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59303149 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59109773 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59024418 |
| 36 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57783523 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.56508638 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53416988 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.53343239 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52507844 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49845397 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.49013471 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46700193 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44584715 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44488454 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40961887 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40952817 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39293281 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34875041 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30798802 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29909663 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.29766544 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28207281 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26205422 |
| 55 | * Tuberculosis_Homo sapiens_hsa05152 | 1.24951605 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24417188 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 1.23729664 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23497413 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22686460 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22673077 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21854780 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.19235640 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19114134 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15926369 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.15388298 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14243462 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12761326 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12460495 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 1.09025369 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 1.08973050 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.08816767 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08739277 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07025129 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06863984 |
| 75 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06672063 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 1.06311985 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06086255 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05715024 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05427193 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05262400 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 1.02092495 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01849891 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01667101 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01625127 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00016130 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.99365119 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98954796 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98668391 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97863727 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96958112 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94712135 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94554014 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92139502 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91756491 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91572793 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91391676 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91358490 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90692666 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90396572 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88076799 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85966663 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85109399 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84155583 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83952759 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83537108 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82411439 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80947085 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80576214 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80570701 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80130493 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79154732 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79061767 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78106740 |
| 114 | RNA polymerase_Homo sapiens_hsa03020 | 0.77646739 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.77022451 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76817294 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76069863 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.73982567 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73962658 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72395628 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.72393211 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72280063 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71622024 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.71210297 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67335341 |
| 126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66923376 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63921477 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.62590356 |
| 129 | Protein export_Homo sapiens_hsa03060 | 0.61154052 |
| 130 | Cell cycle_Homo sapiens_hsa04110 | 0.60661039 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57559334 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57419016 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.56815100 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55747330 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55156482 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54309653 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54011536 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.53552944 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52486973 |
| 140 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45572429 |
| 141 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45281055 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44497986 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43588922 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42160385 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.40158588 |
| 146 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39566098 |
| 147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39383815 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38297986 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37933519 |
| 150 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37471655 |
| 151 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35360608 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34349758 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34211992 |
| 154 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33874963 |
| 155 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33816793 |
| 156 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33614006 |
| 157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33561773 |
| 158 | Prostate cancer_Homo sapiens_hsa05215 | 0.32964074 |
| 159 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32151900 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29851201 |

